Author: openjargon

BlueScope Steel Ltd (ASX: BSL) shares are charging higher on Tuesday morning.

At the time of writing, the steel products company’s shares are up 20% to $29.22.

This compares favourably to the ASX 200 index, which is up 0.2% in early trade.

Why are BlueScope shares charging higher?

Investors have been scrambling to buy the company’s shares this morning following the release of an announcement after the market close on Monday in response to takeover speculation in the media.

Well, it turns out that the speculation was correct, with BlueScope revealing that it has received four takeover offers since 2024 from the same suitor.

According to the release, on 12 December it received an unsolicited, non-binding, and indicative proposal from an Australian and US consortium to acquire all BlueScope shares by way of a scheme of arrangement.

The consortium, which comprises SGH Ltd (ASX: SGH) and US-based Steel Dynamics (NASDAQ: STLD), has tabled an offer of $30.00 cash per BlueScope share.

The company notes that the indicative proposal would see SGH acquire all of BlueScope’s shares and then on-sell BlueScope’s North American businesses to Steel Dynamics.

The proposal is subject to a number of conditions. This includes exclusivity, due diligence, no material adverse change in BlueScope’s business, a unanimous recommendation from the BlueScope board, approval of BlueScope shareholders, no further share buy-backs, final approvals from SGH and Steel Dynamics’ boards, and necessary regulatory approvals.

BlueScope also highlights that the indicative proposal includes highly conditional debt funding support.

What’s next?

BlueScope is yet to make a decision on this proposal and is considering the offer.

However, it is worth noting that after rejecting previous offers of $24.00 per share, $27.50 per share, and $29.00 per share “as they significantly undervalued BlueScope and its future prospects, and presented significant execution risk in relation to regulatory outcomes”, it remains to be seen whether this latest proposal will be enough to get a deal over the line.

Commenting on the offer, SGH’s managing director and CEO, Ryan Stokes, said:

We believe BlueScope’s Australian business is a strong strategic fit for SGH and we have a proven track record of driving performance improvement in domestic industrial businesses. We intend to leverage our disciplined operating model and capital allocation approach to deliver better outcomes for stakeholders.

Steel Dynamics’ CEO, Mark Millett, adds:

We believe the acquisition of BlueScope’s North American Assets will be highly complementary to our existing operations and further expands our capabilities domestically. The combination of BSL’s North American teams and assets with SDI would be an excellent fit in every sense and create value for all stakeholders.

The post BlueScope shares jump 20% on takeover news appeared first on The Motley Fool Australia.

More reading

• SGH confirms $13.2 billion acquisition offer for BlueScope Steel
• BlueScope fields $30-per-share takeover bid from SGH, Steel Dynamics
• 5 things to watch on the ASX 200 on Tuesday
• 3 reasons to buy BlueScope Steel shares now
• All systems go for BlueScope Steel shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Steel Dynamics. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

2025 was a year of disappointment for CSL Ltd (ASX: CSL) shares and shareholders.

The biotechnology leader was amongst the worst performers on the S&P/ASX 200 Index (ASX: XJO) with a decline that shocked the investment world.

The question now is whether this high-quality laggard from last year can outperform that benchmark in 2026 as fundamentals stabilise and sentiment improves.

Looking ahead, I believe the setup is quietly improving, which raises a genuine case for CSL to outperform the ASX 200 Index.

Why CSL shares fell so hard in 2025

At a headline level, CSL’s FY25 result was not a disaster. Group earnings came in slightly ahead of expectations, helped by lower tax and operating costs. The problem was where the growth came from, and where it didn’t.

The market had been positioning CSL Behring, the key plasma therapies division, as the engine room of long-term growth.

Instead, that business barely grew in the second half of FY25. Revenue at CSL Behring increased just 1% in the second half, with flagship immunoglobulin sales declining by 1%. This was deeply disappointing given that Behring had been expected to drive double-digit earnings per share growth for much of the coming decade.

Adding to the pain, management cut its FY26 guidance in the following months, reducing expected revenue growth to around 3% and net profit growth to roughly 6% at the midpoint. The key driver was weaker-than-expected influenza vaccination rates in the US, which weighed on the Seqirus vaccines business. CSL also delayed plans to demerge Seqirus, choosing to wait for conditions in the US vaccine market to improve, and warned of albumin weakness in China.

The core of the investment case remains intact

At its heart, CSL is a plasma powerhouse. It is one of just three tier 1 plasma therapy companies globally, along with Grifols and Takeda, operating in an oligopolistic and highly consolidated market. Plasma collection is the key constraint in production, and CSL is exceptionally well-positioned, owning roughly 30% of global plasma collection centres after years of heavy investment.

That scale matters. It creates high barriers to entry, supports pricing power, and allows CSL to benefit disproportionately as plasma supply conditions normalise.

Encouragingly, plasma efficiency initiatives are already underway with the Horizon project. Management expects plasma gross margins to recover meaningfully by 2028, with the bulk of that improvement driven by faster and larger plasma collections. These benefits have not yet fully flowed through earnings, which means 2026 could mark the beginning of visible margin recovery.

Why 2026 could look better than 2025

For CSL to outperform the ASX 200 in 2026, it doesn’t need everything to go right. It just needs less to go wrong.

Expectations are now firmly lower. The vaccines business is now a smaller part of the earnings mix than many assume. Plasma margins are likely to improve as efficiency initiatives take hold. And long-term demand drivers for immunoglobulins remain intact.

I don’t think sentiment needs to return to peak optimism for CSL shares to beat the index. A combination of stabilising earnings, early signs of margin recovery, and improved sentiment could be enough to drive relative outperformance from a reset base.

What could still go wrong

That said, CSL is not without risk. Gene therapy remains the biggest long-term threat to plasma-derived treatments, aiming to cure rather than treat disease. Adoption may be slow due to cost, but the risk is real. Competition in haemophilia and hereditary angioedema also continues to pressure certain segments.

And research and development (R&D) outcomes are, by nature, uncertain.

However, I believe that CSL’s long track record of disciplined capital allocation and commercial-focused R&D reduces the risk of further value destruction.

Foolish Takeaway

If the ASX 200 delivers a solid return in 2026, I think CSL shares have a credible path to doing better.

The business remains a global leader with competitive advantages, improving plasma economics, and long-term growth drivers that have not gone away.

After a painful reset in 2025, expectations are lower, its valuation is more reasonable, and the risk-reward looks more balanced. I wouldn’t expect fireworks. But if margins begin to recover and sentiment improves even modestly, CSL shares could beat the ASX 200 in 2026 and remind investors why the company has been a long-term winner in the first place.

The post Could CSL shares outperform the ASX 200 in 2026? appeared first on The Motley Fool Australia.

More reading

• Why did CSL shares crash 39% in 2025?
• My best ASX 200 shares to buy in January
• What I look for in ASX shares when uncertainty is everywhere
• Brokers name 3 ASX shares to buy today
• 5 fantastic ASX ETFs for beginners in 2026

Motley Fool contributor Grace Alvino has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

At the beginning of a new year, I like to narrow my focus rather than expand it. Instead of looking at dozens of ASX stocks, I concentrate on a small group of businesses I would genuinely be happy to own for the long term.

These are companies with proven models, clear growth pathways, and management teams that have shown they can execute. They are not risk-free, but they are businesses I believe have the right foundations in place.

With that in mind, here are five ASX stocks that stand out to me as 2026 gets underway.

Sigma Healthcare Ltd (ASX: SIG)

Sigma has quietly become a very different business over the past year.

The merger with Chemist Warehouse has created a vertically integrated healthcare group with scale across wholesale distribution, franchising, and retail. With hundreds of pharmacies under its umbrella, Sigma now sits at the centre of Australia’s community pharmacy network.

Healthcare demand is structural rather than cyclical, which gives Sigma resilience. As integration benefits flow through and scale advantages are realised, I think this ASX stock has the potential to deliver robust growth into 2026 and beyond.

TechnologyOne Ltd (ASX: TNE)

TechnologyOne is another ASX stock that I would consider buying in 2026.

Its enterprise software is deeply embedded in government, education, and large organisations, where switching costs are high and contracts are long-dated. The ongoing transition to a SaaS model has improved revenue visibility, while its international expansion provides an additional growth lever.

It’s not a flashy stock, but it’s exactly the kind of business I want exposure to when markets start rewarding reliability again.

Wesfarmers (ASX: WES)

Wesfarmers could be a key long-term portfolio holding.

With its Bunnings, Kmart, Officeworks, and healthcare businesses, Wesfarmers benefits from diversification and disciplined capital allocation. Management has repeatedly shown a willingness to reshape the portfolio and reinvest where returns look attractive.

As conditions normalise in 2026, I see Wesfarmers continuing to compound steadily.

Lovisa Holdings Ltd (ASX: LOV)

Lovisa brings a different dynamic to the mix.

It’s a globally scaled specialty retailer of fashion jewellery with a fast-moving store rollout model and a clear focus on return on capital. While retail can be volatile, Lovisa’s international footprint and ability to quickly adapt ranges and pricing give it more flexibility than most.

If consumer confidence improves in 2026, Lovisa could benefit from both operating leverage and continued store expansion across global markets.

DroneShield Ltd (ASX: DRO)

DroneShield is the highest-risk stock on this list, and potentially the highest reward.

The company operates in counter-drone technology, a market that is becoming increasingly important for defence, government, and critical infrastructure. While contract timing can make results lumpy, the underlying demand drivers are structural, not cyclical.

As global defence spending remains elevated, DroneShield’s technology and growing customer base could position it well heading into 2026, provided execution continues.

The post My top 5 ASX stocks to buy in early 2026 appeared first on The Motley Fool Australia.

More reading

• 2 incredible ASX 200 shares I’d buy with $2,000 right now
• Why did DroneShield shares rocket 300% in 2025?
• These are the 10 most shorted ASX shares
• Is Wesfarmers stock a buy for its 3.6% dividend yield?
• EOS shares are near all-time highs. Here’s why I think $15 is next in 2026

Motley Fool contributor Grace Alvino has positions in DroneShield, Lovisa, and Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Lovisa, Technology One, and Wesfarmers. The Motley Fool Australia has recommended Lovisa, Technology One, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Telstra Group Ltd (ASX: TLS) share price is essentially where it was six months ago, as the chart below shows. Experts think the ASX telco share could be headed for positive returns from here.

Telstra is the clear leader of the telecommunications space of Australia with the most subscribers, the best spectrum assets, and the widest network coverage. This gives the company a strong foundation to deliver solid earnings and dividends.

Rising profit certainly would help provide a tailwind for a higher share price, though that’s not guaranteed to happen. It partly depends on company updates, and it partly depends on wider investor confidence about the entire (ASX) share market.

Let’s see where experts think the Telstra share price could be in a year and what that could mean for a $10,000 investment today.

Expert views on the ASX telco share

According to CMC Markets, of four recent analyst ratings, there are two buy ratings and two hold ratings. That averages out to a generally positive view on the business.

A price target is where analysts think the share price will be in 12 months from the investment call.

CMC Markets says that the average price target is $5 from those four recent analyst calls, suggesting a possible rise of 3% within the next year (at the time of writing). That wouldn’t be a huge return, though the most optimistic price target suggests a possible rise of more than 11% within a year.

However, there’s more to the return than just the Telstra share price – dividend payments also play their part.

The forecast on CMC Markets suggests that the ASX telco share could pay an annual dividend of 20 cents per share in the 2026 financial year. At the current Telstra share price, that translates into a possible grossed-up dividend yield of 5.9%, including franking credits, or 4.1% excluding them.

Therefore, the ‘total shareholder return’ (which excludes franking credits) is currently projected to be around 7% for 2026.

What could this mean for a $10,000 investment in Telstra shares?

A $10,000 investment could deliver decent performance for a shareholder in the year ahead. A 3% rise would mean the capital value grows to approximately $10,300.

Meanwhile, the dividend would translate into roughly $410 of an annual cash payment, or roughly $585 of grossed-up dividend income, including the franking credits. That’d be total wealth growth of just over $700.

Time will tell how much of a return Telstra actually makes, but there’s a fair chance it could outperform the S&P/ASX 200 Index (ASX: XJO), particularly if Telstra’s net profit outperforms expectations.

According to the projection on CMC Markets, Telstra could generate earnings per share (EPS) of 20.5 cents in FY26. That means the Telstra share price is trading at under 24x FY26’s estimated earnings.

The post Forecast: Here’s what $10,000 invested in Telstra shares could be worth next year appeared first on The Motley Fool Australia.

More reading

• Why I think Telstra and Woolworths shares are buys for passive income
• I would invest $5,000 in these ASX 300 shares in January
• $20,000 in excess savings? Here’s how to try and turn that into a second income in 2026
• 5 fantastic ASX ETFs for beginners in 2026
• 3 ASX dividend shares to buy for passive income in 2026

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If passive income had a postcode, it would likely be shared by the 2 major ASX energy stocks, Woodside Energy Group Ltd (ASX: WDS) and Santos Ltd (ASX: STO).

Neither stock is exciting in the Silicon Valley sense, but that’s kind of the point. Passive income isn’t about adrenaline; it’s about reliability.

And these 2 major ASX oil and gas stocks continue to offer sizeable and consistent cash returns to shareholders. Let’s have a closer look.

Woodside

Let’s start with Woodside Energy, the grand old dame of the ASX energy sector. The $45 billion ASX energy stock has turned its sprawling LNG empire into a dividend machine. It is helped by long-dated contracts, disciplined capital spending, and a management team that treats shareholder payouts like a sacred ritual.

Even as oil and gas prices wobble, Woodside’s diversified portfolio and conservative balance sheet give it room to keep distributions flowing. The result? Fully franked dividends that make income investors feel like they’re still invited to the party, even when energy markets cool.

At a current share price of $23.66, the company is offering a fully franked dividend yield of roughly 7.05%. That is a standout number when you compare it to many of the large-cap stocks on the market today. In the last financial year, Woodside paid out close to $1.65 per share in dividends.

Of course, Woodside isn’t risk-free. Big projects mean big capital requirements, and the global energy transition looms large. But for now, LNG remains in demand, Asia keeps buying, and Woodside keeps writing cheques. For passive income seekers, that’s the holy trinity.

Santos

Then there’s Santos, the slightly scrappier but no less cash-hungry cousin. This ASX energy stock doesn’t have Woodside’s scale, but it makes up for it with operational focus and a knack for sweating its assets.

From PNG to Queensland, Santos has built a portfolio that throws off reliable free cash flow, the lifeblood of dividends. Santos’ appeal lies in its payout discipline. Management has made it clear: dividends matter.

That commitment has translated into yields that regularly turn heads, especially for investors tired of waiting for growth stocks to grow up. Add in exposure to LNG and domestic gas — both still critical to Australia’s energy mix — and Santos looks like a steady income workhorse rather than a boom-or-bust cowboy.

The ASX energy stock still boasts a respectable dividend yield of approximately 5.9% based on recent payouts and its share price of $6.15 at the time of writing.

The company already pays out a meaningful share of its free cash flow and expects to lift those returns from 2026. That focus on rewarding investors has captured the attention of those seeking both income and long-term growth.

Naturally, there are wrinkles. Santos carries more balance-sheet risk than Woodside and faces ongoing regulatory and environmental scrutiny. But as long as gas remains essential to keeping the lights on, income investors will get a slice.

The post After strong dividends? Look at these 2 major ASX energy stocks appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Leading brokers name 3 ASX shares to buy today
• Woodside shares outperforming today amid US intervention in oil rich Venezuela
• Buy, hold, sell: Light & Wonder, NAB, and Woodside shares
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This ASX tech share was the best share in the technology sector last year.

Codan Ltd (ASX: CDA) soared 76.5% in 2025. But in the past month, the shine has dulled as the tech stock lost 6% in value.

After rocketing to a fresh all-time high of $36.92 in early November, Codan’s share price has stumbled. In just two months, the ASX tech share has shed 21.5% from its peak price.

Monday delivered another tiny dent, with Codan closing at $28.97, 0.2% lower on the day.

Tech, but not as you know it

Codan isn’t your typical ASX tech play. Based in Adelaide, the company runs a two-engine business spanning communications and metal detection. It’s an unusual mix that gives it exposure to both defence budgets and goldfields.

That blend is increasingly working in its favour.

The communications division has emerged as Codan’s growth powerhouse, designing and manufacturing mission-critical communications systems, drones, and defence and public safety equipment.

As defence spending rises globally, the ASX tech share is shifting away from the boom-and-bust cycles that come with gold prospecting.

Meanwhile, its Minelab brand — acquired nearly two decades ago — remains a global leader in metal detection. Codan’s products are used everywhere from weekend gold hunters to humanitarian demining operations and security agencies.

Gold, growth and a dream run

The ASX tech share was on fire in 2025, with the stock up over 76%, including a blistering 20% surge in October alone.

The numbers backed it up. In FY25, group revenue jumped 22%, EBIT climbed 28%, and net profit after tax (NPAT) rose 27%. Communications stole the show, delivering 26% revenue growth and a 34% lift in profits.

Gold has also played its part. Prices surged to a new record, turbocharging demand for Minelab detectors — particularly across Africa.

Valuation reality check

So why the sudden wobble?

Valuation looks to be the culprit. After such a blistering run, investors appear to be locking in profits, and analysts are warning that much of the good news may already be priced in, with market watchers’ recommendations being neutral.

Broker sentiment has cooled significantly in the past few months. Many now see the ASX tech share trading closer to fair value than it did months earlier. The average 12-month broker price target is $34.59, suggesting a 19% upside from the current share price.

Petra Capital has a hold rating on Codan with a 12-month share price target of $32.70.

Canaccord Genuity is the most upbeat broker. It seems to think that Codan’s long-term story is intact and has a buy rating with a $37.54 target, which implies a 29% upside.

The post Has this red-hot ASX tech share hit the brakes? appeared first on The Motley Fool Australia.

More reading

• Top 5 ASX 200 tech shares for growth in 2025
• Fastest rising ASX 200 share of each market sector in 2025

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Cryptocurrency, or crypto for short, surged to all-time highs by the third quarter of 2025 as investor interest in major players like Bitcoin (CRYPTO: BTC) peaked. 

Volatility returned towards the end of the calendar year as sentiment cooled and risk appetites shifted. As a result, much of the huge gains seen earlier in the year were reversed by the 31st of December.

Bitcoin declined around 17% throughout 2025, XRP (CRYPTO: XRP) dropped around 30%, and Dogecoin (CRYPTO: DOGE) dropped just over 70% in 2025.

As we move closer into the new year, among Bitcoin, XRP, and Dogecoin, which is the better buy for investors?

The case for Bitcoin

In 2025, Bitcoin suffered the biggest price plummet seen since 2021. By November, the coin’s value had dropped to around US$85,000 per coin. While Bitcoin regained some of that value in the weeks after, it slumped again in December. For context, Bitcoin peaked at US$124,739 per coin in early October.

So far in 2026, the cryptocurrency has climbed 4.92%, sparking excitement that it could be on a path for recovery.

Bitcoin is widely regarded as the global leader in the cryptocurrency market. It has a fixed supply, is experiencing growing institutional adoption, and is dominant in the cryptocurrency space.

The downside is that Bitcoin is less likely to be as explosive as some of the smaller cryptocurrencies. But as it is generally considered one of the most reliable coins to hold long term, it would be the best option for risk-averse, longer-term investors in 2026.

The case for XRP

XRP was one of the fastest-rising altcoins in 2025. It had explosive growth of over 56% in early July alone, rising to an annual high of US$3.65 per coin. It then tumbled just over 47% by the close of 2025.

In 2026, so far, XRP has recovered 16.29% of its value. At the time of writing, it is trading for US$2.14 per token.

XRP is known for being a fast and low-cost global payment. It acts as a bridge between different currencies, without the need for traditional banks. If the uptake of the technology continues in 2026, it has the potential to outperform major coins like Bitcoin. 

The downside is that XRP comes with a lot more risk, so this is the best option for investors who want higher growth and have a larger appetite for risk.

The case for Dogecoin

Dogecoin was launched as a meme-based parody of Bitcoin in 2013 and has been a wildly volatile token ever since. It is primarily driven by sentiment, community support, and social media attention, rather than any fundamental factors. 

There was a huge spike in interest from investors in late-2025 and early-2025, but over the year, the coin shed around 70% of its value. 

So far in 2026, Dogecoin has jumped 24.44% to 15 cents per coin. 

The benefits of this coin are that it can surge quickly. But it lacks the institutional backing that Bitcoin or XRP have, so it’s a high-risk option most suited to short-term investors. 

So which is the best option for investors?

There is no crystal ball to tell us how the crypto market will play out in 2026, so the answer to this question depends on an investors’ risk appetite. 

Bitcoin is a more reliable and stable play. Meanwhile, XRP has the potential to yield explosive returns to those willing to take on more risk, and Dogecoin is best suited for short-term traders.

The post Better Buy in 2026: XRP, Dogecoin, or Bitcoin? appeared first on The Motley Fool Australia.

More reading

• Will the Bitcoin price crash in 2026?

Motley Fool contributor Samantha Menzies has positions in Bitcoin. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bitcoin and XRP. The Motley Fool Australia has positions in and has recommended Bitcoin. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Insurance Australia Group (ASX: IAG) share price is in focus after the company announced it has successfully integrated RACQ Insurance into its group reinsurance programs, expanding its whole of account quota share (WAQS) coverage to 35% of the consolidated business.

What did Insurance Australia Group report?

• RACQ Insurance (RACQI) now included in IAG’s main catastrophe reinsurance cover and WAQS arrangements
• WAQS coverage expanded to 35% of IAG’s consolidated business, up by 2.5%
• Catastrophe reinsurance program for 2026 placed, providing cover for two events up to $10 billion, with attachment at $500 million
• Aggregate stop-loss protection now covers RACQI, providing about $1 billion in natural peril downside protection per year through to FY29

What else do investors need to know?

Previously, after acquiring RACQI on 1 September 2025, IAG had maintained RACQI’s own separate, standalone reinsurance program. Today’s integration brings RACQI fully into the group’s broader reinsurance protections, aiming for cost savings and risk reduction.

IAG’s move comes as global reinsurance markets have improved in 2025, enabling the company to renew protection on more favourable terms. With broad support from reinsurance partners, IAG has further reduced the volatility of its earnings outlook.

The company will release its half-year results for the six months to 31 December 2025 on 12 February 2026.

What did Insurance Australia Group management say?

Chief Financial Officer William McDonnell said:

We are pleased to have integrated the RACQI business into the overall reinsurance program which will achieve the targeted synergies. Global reinsurance markets have improved during 2025, allowing us to renew reinsurance protection favourably relative to expectations. In addition, IAG received strong support from reinsurance partners in expanding the overall program, resulting in a further reduction in the volatility of our earnings.

What’s next for Insurance Australia Group?

With RACQI now fully part of IAG’s overall reinsurance structure, management expects significant operational synergies and greater resilience against large insurance events. The expanded WAQS and aggregate stop-loss protection are designed to reduce earnings volatility and better manage risk exposure from catastrophes into FY29.

Investors can look forward to a further update when IAG releases its financial results in February 2026, providing more colour on the benefits and financial impacts of this integration.

Insurance Australia Group share price snapshot

Over the past 12 months, IAG shares have declined 8%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post IAG integrates RACQ Insurance into reinsurance appeared first on The Motley Fool Australia.

More reading

• Monadelphous awarded $175 million BHP contract: Key details for investors
• SGH confirms $13.2 billion acquisition offer for BlueScope Steel
• BlueScope fields $30-per-share takeover bid from SGH, Steel Dynamics
• 2 incredible ASX 200 shares I’d buy with $2,000 right now
• Top 5 ASX 200 tech shares for growth in 2025

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Monadelphous Group Ltd (ASX: MND) share price is in focus after the company announced it has secured a $175 million construction contract with BHP Group Ltd (ASX: BHP) at Finucane Island, Port Hedland. The contract covers major civil, structural, mechanical, piping, and electrical works during a planned shutdown.

What did Monadelphous report?

• Awarded a $175 million construction contract with BHP for a car dumper project
• Scope includes civil, structural, mechanical, piping, and electrical works
• Project to be delivered during a planned major shutdown at Finucane Island
• Builds on the previous successful delivery of the Car Dumper 3 Project at Nelson Point
• Reinforces Monadelphous’ strong relationship with BHP

What else do investors need to know?

This new contract highlights Monadelphous’ reputation and experience in major resources projects across Australia. The company continues to grow its footprint with BHP and other tier-one mining customers through repeat project awards.

The works will be delivered by Monadelphous’ Engineering Construction division, leveraging the company’s multidisciplinary capabilities. Monadelphous also has operations across the maintenance, infrastructure, and energy sectors, with more than 50 years of industry experience.

What’s next for Monadelphous?

Monadelphous will focus on delivering this contract safely and efficiently, supporting BHP’s infrastructure program. The company’s ongoing pipeline includes a mix of construction, maintenance, and industrial services across multiple sectors.

Investors will be watching for updates on project progress, as well as further contract wins, particularly with major clients in the resources and energy industries.

Monadelphous share price snapshot

Over the past 12 months, Monadelphous shares have soared 87%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post Monadelphous awarded $175 million BHP contract: Key details for investors appeared first on The Motley Fool Australia.

More reading

• SGH confirms $13.2 billion acquisition offer for BlueScope Steel
• Silver rebounds putting ASX silver stocks back in focus
• BlueScope fields $30-per-share takeover bid from SGH, Steel Dynamics
• 2 incredible ASX 200 shares I’d buy with $2,000 right now
• Top 5 ASX 200 tech shares for growth in 2025

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The SGH Ltd (ASX: SGH) share price is in focus today after the company confirmed a joint proposal with Steel Dynamics Inc (NASDAQ: STLD) to acquire BlueScope Steel Ltd (ASX: BSL) for an all-cash offer of $30 per share, representing a 27% premium to BlueScope’s last close and valuing the deal at $13.2 billion.

What did SGH report?

• Confirmed a Non-Binding Indicative Offer (NBIO) to acquire 100% of BlueScope Steel Ltd for $30.00 per share in cash
• The offer represents a 27% premium to BlueScope’s last close and a 33% premium to its 3-month and 52-week average prices
• Total equity value of the deal is $13.2 billion (AUD)
• Following the proposed transaction, SGH would retain BlueScope’s Australian, Asian, and Pacific businesses while Steel Dynamics acquires North American operations
• No new equity required; funding to be sourced from existing cash reserves and debt

What else do investors need to know?

The SGH and Steel Dynamics proposal would see BlueScope’s North American operations on-sold to Steel Dynamics, while SGH retains the Australia and Rest of World businesses. The exclusive partnership between SGH and Steel Dynamics is subject to due diligence and regulatory approvals typical of deals of this size.

SGH intends to offer current BlueScope directors board positions for continuity and plans to keep key management in place for the ongoing Australian business. The companies emphasise that there is no certainty the proposal will lead to a binding agreement, and the offer price will adjust down for any BlueScope dividends paid after 12 December 2025.

What did SGH management say?

Ryan Stokes, Managing Director & Chief Executive Officer of SGH, said:

We believe BlueScope’s Australian business is a strong strategic fit for SGH and we have a proven track record of driving performance improvement in domestic industrial businesses. We intend to leverage our disciplined operating model and capital allocation approach to deliver better outcomes for stakeholders.

What’s next for SGH?

SGH and Steel Dynamics will commence confirmatory due diligence, having committed substantial resources to progress the transaction. SGH will update investors as developments arise and has already lined up financial and legal advisors to support the process.

There is no guarantee the proposal advances to a definitive agreement, but both companies are confident in their ability to secure regulatory and shareholder approvals. Investors should watch for further updates as negotiations proceed.

SGH share price snapshot

Over the past 12 months, SGH shares have declined 1%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post SGH confirms $13.2 billion acquisition offer for BlueScope Steel appeared first on The Motley Fool Australia.

More reading

• Monadelphous awarded $175 million BHP contract: Key details for investors
• BlueScope fields $30-per-share takeover bid from SGH, Steel Dynamics
• 2 incredible ASX 200 shares I’d buy with $2,000 right now
• 5 things to watch on the ASX 200 on Tuesday
• Top 5 ASX 200 tech shares for growth in 2025

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.